首页> 美国卫生研究院文献>PLoS Clinical Trials >PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue
【2h】

PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue

机译:PRCC-TFE3双融合FISH检测:一种在石蜡包埋组织中鉴定PRCC-TFE3肾细胞癌的新方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

PRCC-TFE3 renal cell carcinoma (RCC) is one of the most common types of Xp11.2 translocation renal cell carcinoma (tRCC), of which the diagnosis mainly relies on reverse transcription-polymerase chain reaction (RT-PCR) or chromosomal analysis in fresh frozen samples. Herein, we developed a new dual-fusion fluorescence in situ hybridization (FISH) probe to succinctly identify PRCC-TFE3 RCC in paraffin-embedded tissue. We immunohistochemically analyzed TFE3 and cathepsin K expression in 23 cases of Xp11.2 tRCC which had been confirmed by break-apart TFE3 FISH probe. Next, the dual-fusion FISH assay was performed on these selected cases. Twenty typical cases of clear renal cell carcinoma and 20 cases of papillary renal cell carcinoma were collected as control groups. Seven cases were finally confirmed as PRCC-TFE3 RCC by FISH detection, emerging dual-fusion signals, of which 2 cases were identified as PRCC-TFE3 RCC by RT-PCR previously. All remaining cases were negative for the PRCC-TFE3 rearrangement by FISH. The TFE3 immunohistochemistry was positive in 22/23 cases and the cathepsin K was positive in 16/23 cases. All 7 PRCC-TFE3 RCCs showed positive cathepsin K immunoreactivity. Our results reveal that PRCC-TFE3 dual-fusion FISH probe is an efficient and concise technique for diagnosing PRCC-TFE3 RCC in paraffin-embedded tissue.
机译:PRCC-TFE3肾细胞癌(RCC)是Xp11.2易位性肾细胞癌(tRCC)的最常见类型之一,其诊断主要依靠逆转录聚合酶链反应(RT-PCR)或染色体分析。新鲜冷冻样品。本文中,我们开发了一种新型的双融合荧光原位杂交(FISH)探针,可在石蜡包埋的组织中简洁地鉴定PRCC-TFE3 RCC。我们对23例Xp11.2 tRCC病例中的TFE3和组织蛋白酶K表达进行了免疫组织化学分析,这已通过TFE3 FISH分离探针证实。接下来,对这些选定病例进行双重融合FISH分析。收集20例典型的透明肾细胞癌和20例乳头状肾细胞癌作为对照组。最终通过FISH检测确认7例为PRCC-TFE3 RCC,出现双融合信号,其中2例先前通过RT-PCR鉴定为PRCC-TFE3 RCC。其余所有病例均通过FISH对PRCC-TFE3重排呈阴性。 TFE3免疫组化阳性22/23例,组织蛋白酶K阳性16/23例。所有7个PRCC-TFE3 RCC均显示出组织蛋白酶K免疫阳性。我们的结果表明,PRCC-TFE3双融合FISH探针是诊断石蜡包埋组织中PRCC-TFE3 RCC的有效且简洁的技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号